Post Approval Study of the CyPass System

NATerminatedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

October 12, 2017

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Primary Open-angle GlaucomaCataract
Interventions
DEVICE

CyPass Micro-Stent implanted with CyPass 241-S applier

CyPass System (Model 241-S) consists of the CyPass Micro-Stent contained in a loading device (loader) and the CyPass applier.The CyPass Micro-Stent is an implantable medical device intended for long term use.

PROCEDURE

Cataract surgery

Cataract surgery, followed by implantation of the CyPass Micro-Stent in one eye (the study eye) at the surgery visit

Trial Locations (20)

17201

Alcon Investigative Site, Chambersburg

19004

Alcon Investigative Site, Bala-Cynwyd

30060

Alcon Investigative Site, Marietta

30501

Alcon Investigative Site, Gainesville

32256

Alcon Investigative Site, Jacksonville

32405

Alcon Investigative Site, Panama City

48026

Alcon Investigative Site, Fraser

53142

Alcon Investigative Site, Kenosha

53405

Alcon Investigative Site, Racine

63131

Alcon Investigative Site, St Louis

63141

Alcon Investivative Site, St Louis

67846

Alcon Investigative Site, Garden City

77030

Alcon Investigative Site, Houston

78731

Alcon Investigative Site, Austin

79902

Alcon Investigative Site, El Paso

80528

Alcon Investigative Site, Fort Collins

85016

Alcon Investigative Site, Phoenix

92868

Alcon Investigative Site, Orange

08361

Alcon Investigative Site, Vineland

98004-3012

Alcon Investigative Site, Bellevue

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT03273907 - Post Approval Study of the CyPass System | Biotech Hunter | Biotech Hunter